Nexalin Technology (NXL) Operating Expenses (2021 - 2026)

Nexalin Technology's Operating Expenses history runs 6 years deep, the most recent figure standing at $2.1 million for Q1 2026.

• On a quarterly basis, Operating Expenses rose 4.63% year-over-year to $2.1 million in Q1 2026; TTM through Mar 2026 was $8.7 million, a 0.65% decrease from a year earlier, with the FY2025 full-year figure at $8.6 million, up 9.44% from the prior year.
• Operating Expenses retreated to $2.1 million in Q1 2026 per NXL's latest filing, from $2.6 million in the prior quarter.
• Across five years, Operating Expenses topped out at $2.9 million in Q4 2024 and bottomed at $651219.0 in Q3 2022.
• The 5-year median for Operating Expenses is $1.6 million (2023), against an average of $1.6 million.
• Across the five-year window, Operating Expenses tumbled 64.65% in 2022 and surged 274.02% in 2023, its largest moves.
• Year by year, Operating Expenses stood at $751174.0 in 2022, then surged by 118.3% to $1.6 million in 2023, then soared by 76.55% to $2.9 million in 2024, then dropped by 11.43% to $2.6 million in 2025, then slipped by 16.81% to $2.1 million in 2026.
• Per Business Quant, the three latest NXL Operating Expenses figures stand at $2.1 million (Q1 2026), $2.6 million (Q4 2025), and $2.4 million (Q3 2025).